EP4364794A3 — Solvate form of (r)-2-amino-3-phenylpropyl carbamate
Assigned to SK Biopharmaceuticals Co Ltd · Expires 2024-07-24 · 2y expired
What this patent protects
The present invention relates to a newly identified solvate form of ( R )-2-amino-3-phenylpropyl carbamate (APC) hydrochloride, a method of preparing APC hydrochloride, and methods of using the same to treat disorders. The invention further relates to methods of producing APC hyd…
USPTO Abstract
The present invention relates to a newly identified solvate form of ( R )-2-amino-3-phenylpropyl carbamate (APC) hydrochloride, a method of preparing APC hydrochloride, and methods of using the same to treat disorders. The invention further relates to methods of producing APC hydrochloride with increased purity.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.